Very early pulmonary function decline in systemic sclerosis: longitudinal evidence from the STRIKE and EUSTAR VEDOSS cohorts
Year: 2026
Type: article
Abstract: Mean forced vital capacity (FVC) at interstitial lung disease (ILD) diagnosis in EUSTAR is approximately 87%, suggesting a period of pulmonary function decline prior to ILD detection. Here we analysed longitudinal pulmonary function trajectories in patients with very early diagnosis of systemic sclerosis (VEDOSS) to identify lung function decline at this very early stage of disease. We performed a retrospective analysis of two independent VEDOSS cohorts from the STRIKE and EUSTAR databases. Patients were included at baseline if they fulfilled VEDOSS criteria but did not meet the 2013 ACR/EULAR systemic sclerosis classification criteria and had at least one follow-up pulmonary function test (PFT). Very Early pulmonary function decline was defined as an absolute ≥ 10% decline in forced vital capacity (FVC), or a 5–9% FVC decline accompanied by a ≥ 15% decline in diffusing capacity of the lung for carbon monoxide (DLCO), at any time during follow-up. Clinical features and available serum biomarkers were compared between progressors and non-progressors. A total of 455 patients (77 STRIKE; 378 EUSTAR) were included. PFT-defined lung function decline was observed in 22.1% of patients in the STRIKE cohort and 17.2% in the EUSTAR cohort. Baseline DLCO was reduced in both cohorts (STRIKE: 90% ±18; EUSTAR: 85% ±16) despite preserved FVC (STRIKE: 102% ±15; EUSTAR: 106% ±16). 46.3% of patients with lung function decline fulfilled the 2013 ACR/EULAR SSc classification criteria during follow-up. Serum markers of extracellular matrix (ECM) turnover comprising the Enhanced Liver Fibrosis (ELF) score, were higher in progressors at baseline and follow-up compared with non-progressors in the STRIKE cohort. Time-to-event analysis demonstrated a cumulative incidence of very early pulmonary function decline of 20.4% (95% CI 15.0–25.4) at 5 years in the combined cohort. A substantial minority of patients with VEDOSS demonstrate measurable pulmonary function decline prior to fulfilment of classification criteria. Elevated markers of ECM turnover support the presence of early fibrotic activity in this subgroup. Our findings warrant the implementation of early ILD detection strategies in patients with very early diagnosis of SSc even if they do not fulfil classification criteria for the disease.
Source: Arthritis Research & Therapy
Authors: Vishal Kakkar, Stefano Di Donato, Nicola Ortalli, Florenzo Iannone, Gábor Kumánovics, Radim Bečvář, Vanessa Smith, Andra Balanescu, Ulf Mueller-Ladner, Roberta Foti, Emmanuel Chatelus, Jelena Colic, Maria De Santis, Sophie Blaise, Katja Perdan Pirkmajer, Lucy Thornton, Veronica Batani, Lesley-Anne Bissell, Silvia Bellando-Randone, Marco Matucci-Cerinic, Yannick Allanore, Francesco Del Galdo
Institutions: University of Leeds, Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, National Institute for Health and Care Research, University of Cagliari, University of Bari Aldo Moro, University of Pecs, Charles University, Institute of Rheumatology, Ghent University, Carol Davila University of Medicine and Pharmacy, Justus-Liebig-Universität Gießen, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco", Hôpitaux Universitaires de Strasbourg, Hôpital d'Hautepierre, Humanitas University, IRCCS Humanitas Research Hospital, Centre Hospitalier Universitaire de Grenoble, Ljubljana University Medical Centre, University of Modena and Reggio Emilia, University of Florence, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Université Paris Cité, Hôpital Cochin
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,690
OpenAlex ID: W7225997899
